EXOC7 |
RALA |
||
---|---|---|---|
Gene Name | exocyst complex component 7 | v-ral simian leukemia viral oncogene homolog A (ras related) | |
Image | No pdb structure | ||
Gene Ontology Annotations | Cellular Component | ||
Molecular Function | |||
Biological Process | |||
Pathways | |||
Drugs | |||
Diseases | |||
GWAS | |||
Protein-Protein Interactions | 26 interactors: AKTIP ARFGEF2 ARPC1A BBS1 BBS2 BBS4 CCDC85B CDC5L DISC1 DLG3 DTNBP1 EXOC2 EXOC4 GRIN2B HGS IFT20 KXD1 PRPF19 RALA RHOQ RTN4IP1 SMARCE1 SSC5D TRAF4 USHBP1 ZC3H14 | 32 interactors: ARF1 CALM1 CNKSR2 EXOC1 EXOC2 EXOC3 EXOC4 EXOC5 EXOC6B EXOC7 EXOC8 FLNA HRAS LRPAP1 LSM2 PIH1D2 PLCD1 PLD1 PPP2R1B RAB34 RAB8B RALBP1 RALGPS1 RAP1A RAP2A RAP2B RASSF5 REPS1 RGL2 RGL4 SMAD4 YBX3 | |
Entrez ID | 23265 | 5898 | |
HPRD ID | 16292 | 01549 | |
Ensembl ID | ENSG00000182473 | ENSG00000006451 | |
Uniprot IDs | B4DJ07 B5MCY9 Q63HP7 Q9UPT5 | P11233 | |
PDB IDs | 1UAD 1ZC3 1ZC4 2A78 2A9K 2BOV | ||
Enriched GO Terms of Interacting Partners? |
|
|
|
Tagcloud ? | adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
||
Tagcloud (Difference) ? | adoptive
antitumor
capability
chimeric
combining
effectors
engineered
fused
genetically
gtp
immunotherapeutic
killer
meaningful
mhc
moieties
ncr1
ncrs
nk
nkp46
partly
proto
ralb
recognition
recognize
regressions
remarkable
retrovirally
termed
|
||
Tagcloud (Intersection) ? |